Structure of activated thrombin-activatable fibrinolysis inhibitor, a molecular link between coagulation and fibrinolysis.

Molecular Cell
Laura SanglasF Xavier Gomis-Rüth

Abstract

Thrombin-activatable fibrinolysis inhibitor (TAFI) is a metallocarboxypeptidase (MCP) that links blood coagulation and fibrinolysis. TAFI hampers fibrin-clot lysis and is a pharmacological target for the treatment of thrombotic conditions. TAFI is transformed through removal of its prodomain by thrombin-thrombomodulin into TAFIa, which is intrinsically unstable and has a short half-life in vivo. Here we show that purified bovine TAFI activated in the presence of a proteinaceous inhibitor renders a stable enzyme-inhibitor complex. Its crystal structure reveals that TAFIa conforms to the alpha/beta-hydrolase fold of MCPs and displays two unique flexible loops on the molecular surface, accounting for structural instability and susceptibility to proteolysis. In addition, point mutations reported to enhance protein stability in vivo are mainly located in the first loop and in another surface region, which is a potential heparin-binding site. The protein inhibitor contacts both the TAFIa active site and an exosite, thus contributing to high inhibitory efficiency.

References

May 1, 1989·Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie·D HendriksM P Lommaert
Jan 1, 1988·Annual Review of Biochemistry·K G MannS Krishnaswamy
Oct 29, 1982·Molecular and Cellular Biochemistry·I Björk, U Lindahl
Oct 1, 1980·The Biochemical Journal·B Wiman
Sep 25, 1982·Journal of Molecular Biology·D C Rees, W N Lipscomb
Jun 16, 1995·The Journal of Biological Chemistry·L BajzarM E Nesheim
Oct 31, 1994·FEBS Letters·N M Hooper
Dec 19, 1995·Proceedings of the National Academy of Sciences of the United States of America·E NormantC Gros
May 1, 1996·Protein Science : a Publication of the Protein Society·F ZappacostaP Pucci
Feb 1, 1996·Journal of Molecular Graphics·R KoradiK Wüthrich
Jan 29, 2000·The European Journal of Neuroscience·A MatsumotoR Matsumoto
May 29, 2003·Current Drug Targets. Cardiovascular & Haematological Disorders·M B BoffaM L Koschinsky
Dec 9, 2003·The Journal of Biological Chemistry·Pauline F MarxJoost C M Meijers
Sep 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·UNKNOWN Collaborative Computational Project, Number 4
Nov 19, 2004·The Journal of Biological Chemistry·Wendy J CarterJames A Huntington
Feb 5, 2005·Pathophysiology of Haemostasis and Thrombosis·Bonno N Bouma, Laurent O Mosnier
Mar 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Irantzu PallarèsF Xavier Gomis-Rüth
Apr 6, 2006·The Journal of Biological Chemistry·Erik CeresaAnn Gils
Nov 18, 2006·Journal of Thrombosis and Thrombolysis·Xinkang WangWilliam A Schumacher
Nov 28, 2006·Frontiers in Bioscience : a Journal and Virtual Library·Johan L Willemse, Dirk F Hendriks
Dec 2, 2006·The Journal of Biological Chemistry·Zuzana ValnickovaJan J Enghild
Feb 22, 2007·Current Pharmaceutical Design·Joan L ArolasLloyd D Fricker
Dec 8, 2007·Circulation Research·Karlien BuelensAnn Gils

❮ Previous
Next ❯

Citations

Sep 22, 2010·The Journal of Biological Chemistry·Peter J Lyons, Lloyd D Fricker
Oct 31, 2009·Microbial Cell Factories·Juan-Miguel Puertas, Jean-Michel Betton
Jun 2, 2011·Hämostaseologie·P J Declerck
Oct 22, 2008·Critical Reviews in Biochemistry and Molecular Biology·F Xavier Gomis-Rüth
Aug 28, 2015·Protein Science : a Publication of the Protein Society·Govindarajan SudhaNarayanaswamy Srinivasan
Nov 20, 2008·Journal of Thrombosis and Haemostasis : JTH·D C Rijken, H R Lijnen
Sep 2, 2009·Journal of Thrombosis and Haemostasis : JTH·J L WillemseD F Hendriks
Jan 31, 2009·Proceedings of the National Academy of Sciences of the United States of America·Laura SanglasJoan L Arolas
Jan 21, 2016·Journal of Thrombosis and Haemostasis : JTH·T Plug, J C M Meijers
Aug 31, 2014·Toxicon : Official Journal of the International Society on Toxinology·Simone VinkPaul F Alewood
May 15, 2010·Biochimie·Daniel FernándezFrancesc X Avilés
May 31, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Anabel OteroDavid Reverter
Aug 24, 2010·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Iva PrunerDragica Radojkovic
May 1, 2021·International Journal of Molecular Sciences·Machteld Sillen, Paul J Declerck
Jun 22, 2021·Thrombosis Research·Patricia Sansilvestri-MorelPhilippe Delerive
Jul 1, 2021·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Ping FangMeijuan Li

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.